The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

Publication | Open Access

DOI Full Paper Access

Citations

References

2008

Year

Anna C. Calkin, Sara Giunti, Karen Sheehy, Choy-Hoong Chew, Vishal Boolell, Y. S. Rajaram, Mark E. Cooper, Karin Jandeleit‐Dahm

Diabetologia

Metabolic SyndromeCardiovascular DiseaseBiochemistryMedicineDiabetesPhysiologyHyperlipidemiaVascular BiologyMicrovascular DysfunctionPharmacologyAdvanced GlycationAtherosclerosisDyslipidemiaOxidative StressHealth Sciences